Cognitive impairment in patients with chronic hepatitis treated with interferon alpha (IFNα): results from a prospective study

European Psychiatry

Volumn 21, Issue 3, 2006, Pages 204-210

  Lieb, Klaus ^a   Engelbrecht, Marc A ^a   Gut, Oliver ^a   Fiebich, Bernd L ^a   Bauer, Joachim ^a   Janssen, Gesa ^b   Schaefer, Martin ^b  

^a UNIVERSITY OF FREIBURG   (Germany)

^b CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

Anxiety; Cognition; Cytokine; Depression; Interferon

Indexed keywords

ALPHA INTERFERON;

ADULT; AGED; ANXIETY DISORDER; ARTICLE; BECK DEPRESSION INVENTORY; CHRONIC HEPATITIS; COGNITIVE DEFECT; CONTROLLED STUDY; CORRELATION ANALYSIS; DEPRESSION; FEMALE; HEPATITIS B; HEPATITIS C; HOSPITAL ANXIETY AND DEPRESSION SCALE; HUMAN; LOW DRUG DOSE; MALE; MEMORY DISORDER; NEUROPSYCHOLOGICAL TEST; PRIORITY JOURNAL; PSYCHOLOGICAL RATING SCALE; RECALL; SELF CONCEPT; SYMPTOM CHECKLIST 90;

ADULT; AGED; ANALYSIS OF VARIANCE; ANTIVIRAL AGENTS; ANXIETY DISORDERS; COGNITION DISORDERS; DEPRESSIVE DISORDER; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; HEPATITIS, CHRONIC; HUMANS; INTERFERON-ALPHA; MALE; MIDDLE AGED; NEUROPSYCHOLOGICAL TESTS; PROSPECTIVE STUDIES; PSYCHIATRIC STATUS RATING SCALES; SELF ASSESSMENT (PSYCHOLOGY);

EID: 33748257103     PISSN: 09249338     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.eurpsy.2004.09.030     Document Type: Article

References (52)

1. Beck A.T., Ward C.H., Mendelson M., Mock J., and Erbaugh J. An inventory for measuring depression. Arch. Gen. Psychiatry 4 (1961) 561-571
2. Benton A.L. Neuropsychological assessment. Annu. Rev. Psychol. 45 (1994) 1-23
3. Capuron L., Neurauter G., Musselman D.L., Lawson D.H., Nemeroff C.B., Fuchs D., et al. Interferon-alpha-induced changes in tryptophan metabolism. Relationship to depression and paroxetine treatment. Biol. Psychiatry 54 (2003) 906-914
4. Carpiniello B., Orru M.G., Baita A., Pariante C.M., and Farci G. Mania induced by withdrawal of treatment with interferon alfa. Arch. Gen. Psychiatry 55 (1998) 88-89
5. Chao C.C., and Hu S. Tumor necrosis factor-alpha potentiates glutamate neurotoxicity in human fetal brain cell cultures. Dev. Neurosci. 16 (1994) 172-179
6. Chao C.C., Hu S., Ehrlich L., and Peterson P.K. Interleukin-1 and tumor necrosis factor-alpha synergistically mediate neurotoxicity: involvement of nitric oxide and of N-methyl-d-aspartate receptors. Brain Behav. Immun. 9 (1995) 355-365
7. Dieperink E., Willenbring M., and Ho S.B. Neuropsychiatric symptoms associated with hepatitis C and interferon alpha: a review. Am. J. Psychiatry 157 (2000) 867-876
8. Fattovich G., Giustina G., Favarato S., and Ruol A. A survey of adverse events in 11,241 patients with chronic viral hepatitis treated with alfa interferon. J. Hepatol. 24 (1996) 38-47
9. Franke G. SCL-90-R: Die Symptom-Checkliste von derogatis-Deutsche Version. 1st ed (2002), Beltz Test, Goettingen GmbH
10. Goldman-Rakic P.S. Circuity of the Primate Prefrontal Cortex and Regulation of Behavior by Representational Memory (1987) 75-81
11. Haria M., and Benfield P. Interferon-alpha-2a. A review of its pharmacological properties and therapeutic use in the management of viral hepatitis. Drugs 50 (1995) 873-896
12. Hauser P., Khosla J., Aurora H., Laurin J., Kling M.A., Hill J., et al. A prospective study of the incidence and open-label treatment of interferon-induced major depressive disorder in patients with hepatitis C. Mol. Psychiatry 7 (2002) 942-947
13. Herrmann C. International experiences with the Hospital Anxiety and Depression Scale-a review of validation data and clinical results. J. Psychosom. Res. 42 (1997) 17-41
14. Heubrock D. The Auditory Verbal Learning Test (AVLT) in clinical and experimental neuropsychology: administration, evaluation and research findings. Z. Differentielle Diagn. Psychol. 13 (1992) 161-174
15. Hu S., Sheng W.S., Ehrlich L.C., Peterson P.K., and Chao C.C. Cytokine effects on glutamate uptake by human astrocytes. Neuroimmunomodulation 7 (2000) 153-159
16. Hunt C.M., Dominitz J.A., Bute B.P., Waters B., Blasi U., and Williams D.M. Effect of interferon-alpha treatment of chronic hepatitis C on health-related quality of life. Dig. Dis. Sci. 42 (1997) 2482-2486
17. Janssen H.L., Brouwer J.T., Van der Mast R.C., and Schalm S.W. Suicide associated with alfa-interferon therapy for chronic viral hepatitis. J. Hepatol. 21 (1994) 241-243
18. Juengling F.D., Ebert D., Gut O., Engelbrecht M.A., Rasenack J., Nitzsche E.U., et al. Prefrontal cortical hypometabolism during low-dose interferon alpha treatment. Psychopharmacology (Berlin) 152 (2000) 383-389
19. Katafuchi T., Take S., and Hori T. Roles of cytokines in the neural-immune interactions: modulation of NMDA responses by IFN-alpha. Neurobiology (Bp.) 3 (1995) 319-327
20. Kirkwood J.M., Bender C., Agarwala S., Tarhini A., Shipe-Spotloe J., Smelko B., et al. Mechanisms and management of toxicities associated with high-dose interferon alfa-2b therapy. J. Clin. Oncol. 20 (2002) 3703-3718
21. Kizilbash A.H., Vanderploeg R.D., and Curtiss G. The effects of depression and anxiety on memory performance. Arch. Clin. Neuropsychol. 17 (2002) 57-67
22. Malaguarnera M., Di F.I., Restuccia S., Pistone G., Ferlito L., and Rampello L. Interferon alpha-induced depression in chronic hepatitis C patients: comparison between different types of interferon alpha. Neuropsychobiology 37 (1998) 93-97
23. Malik U.R., Makower D.F., and Wadler S. Interferon-mediated fatigue. Cancer 92 (2001) 1664-1668
24. McDonald E.M., Mann A.H., and Thomas H.C. Interferons as mediators of psychiatric morbidity. An investigation in a trial of recombinant alpha-interferon in hepatitis-B carriers. Lancet 2 (1987) 1175-1178
25. Mendoza-Fernandez V., Andrew R.D., and Barajas-Lopez C. Interferon-alpha inhibits long-term potentiation and unmasks a long-term depression in the rat hippocampus. Brain Res. 885 (2000) 14-24
26. Meyers C.A., Obbens E.A., Scheibel R.S., and Moser R.P. Neurotoxicity of intraventricularly administered alpha-interferon for leptomeningeal disease. Cancer 68 (1991) 88-92
27. Meyers C.A., Scheibel R.S., and Forman A.D. Persistent neurotoxicity of systemically administered interferon-alpha. Neurology 41 (1991) 672-676
28. Miyaoka H., Otsubo T., Kamijima K., Ishii M., Onuki M., and Mitamura K. Depression from interferon therapy in patients with hepatitis C. Am. J. Psychiatry 156 (1999) 1120
29. Nozaki O., Takagi C., Takaoka K., Takata T., and Yoshida M. Psychiatric manifestations accompanying interferon therapy for patients with chronic hepatitis C: an overview of cases in Japan. Psychiatry Clin. Neurosci. 51 (1997) 175-180
30. Okanoue T., Sakamoto S., Itoh Y., Minami M., Yasui K., Sakamoto M., et al. Side effects of high-dose interferon therapy for chronic hepatitis C. J. Hepatol. 25 (1996) 283-291
31. Oswald W.D., and Roth E. Der Zahlen-Verbindungs-Test (ZVT) Handanweisung. 2nd ed (1994), Verlag für Psychologie, Goettingen, Toronto, Zuerich
32. Pavol M.A., Meyers C.A., Rexer J.L., Valentine A.D., Mattis P.J., and Talpaz M. Pattern of neurobehavioral deficits associated with interferon alfa therapy for leukemia. Neurology 45 (1995) 947-950
33. Prior T.I., and Chue P.S. Psychotic depression occurring after stopping interferon-alpha. J. Clin. Psychopharmacol. 19 (1999) 385-386
34. Renault P.F., and Hoofnagle J.H. Side effects of alpha interferon. Semin. Liver Dis. 9 (1989) 273-277
35. Renault P.F., Hoofnagle J.H., Park Y., Mullen K.D., Peters M., Jones D.B., et al. Psychiatric complications of long-term interferon alfa therapy. Arch. Intern. Med. 147 (1987) 1577-1580
36. Rifflet H., Vuillemin E., Oberti F., Duverger P., Laine P., Garre J.B., et al. Suicidal impulses in patients with chronic viral hepatitis C during or after therapy with interferon alpha. Gastroenterol. Clin. Biol. 22 (1998) 353-357
37. Scalori A., Apale P., Panizzuti F., Mascoli N., Pioltelli P., Pozzi M., et al. Depression during interferon therapy for chronic viral hepatitis: early identification of patients at risk by means of a computerized test. Eur. J. Gastroenterol. Hepatol. 12 (2000) 505-509
38. Schaefer M., Boetsch T., and Laakmann G. Psychosis in a methadone-substituted patient during interferon-alpha treatment of hepatitis C. Addiction 95 (2000) 1101-1104
39. Schaefer M., Engelbrecht M.A., Gut O., Fiebich B.L., Bauer J., Schmidt F., et al. Interferon alpha (IFNalpha) and psychiatric syndromes: a review. Prog Neuropsychopharmacol. Biol. Psychiatry 26 (2002) 731-746
40. Schaefer M., Schmidt F., Horn M., Schmid-Wendtner M.H., and Volkenandt M. Depression during treatment with interferon alpha. Psychosomatics 45 (2004) 176
41. Shad J.A., and McHutchison J.G. Current and future therapies of hepatitis C. Clin. Liver Dis. 5 (2001) 335-359
42. Squire L.R. Memory systems. C. R. Acad. Sci. III 321 (1998) 153-156
43. Squire L.R., and Zola S.M. Episodic memory, semantic memory, and amnesia. Hippocampus 8 (1998) 205-211
44. Strite D., Valentine A.D., and Meyers C.A. Manic episodes in two patients treated with interferon alpha. J. Neuropsychiatry Clin. Neurosci. 9 (1997) 273-276
45. Trask P.C., Esper P., Riba M., and Redman B. Psychiatric side effects of interferon therapy: prevalence, proposed mechanisms, and future directions. J. Clin. Oncol. 18 (2000) 2316-2326
46. Tulving E., and Markowitsch H.J. Episodic and declarative memory: role of the hippocampus. Hippocampus 8 (1998) 198-204
47. Valentine A.D., and Meyers C.A. Successful treatment of interferon-alpha-induced mood disorder with nortriptyline. Psychosomatics 36 (1995) 418-419
48. Valentine A.D., Meyers C.A., Kling M.A., Richelson E., and Hauser P. Mood and cognitive side effects of interferon-alpha therapy. Semin. Oncol. 25 (1998) 39-47
49. Vargha-Khadem F., Gadian D.G., Watkins K.E., Connelly A., Van Paesschen W., and Mishkin M. Differential effects of early hippocampal pathology on episodic and semantic memory. Science 277 (1997) 376-380
50. Wichers M.C., and Maes M. The role of indoleamine 2,3-dioxygenase (IDO) in the pathophysiology of interferon-alpha-induced depression. J. Psychiatry Neurosci. 29 (2004) 11-17
51. Zdilar D., Franco-Bronson K., Buchler N., Locala J.A., and Younossi Z.M. Hepatitis C, interferon alfa, and depression. Hepatology 31 (2000) 1207-1211
52. Zigmond A.S., and Snaith R.P. The Hospital Anxiety and Depression Scale. Acta Psychiatr. Scand. 67 (1983) 361-370